North America Gaucher Disease Market by Manufacturers, Countries, Type and Application, Forecast to 2022

June 2017 | 124 pages | ID: NDC16B91645EN
GlobalInfoResearch

Abstracts

Gaucher disease is an inherited disorder that affects many of the body's organs and tissues. The signs and symptoms of this condition vary widely among affected individuals.

Scope of the Report:

This report focuses on the Gaucher Disease in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.

Market Segment by Manufacturers, this report covers

• Sanofi
• Shire
• Actelion Pharma
• Pfizer
• ISU Pharm

Market Segment by Countries, covering

• United States
• Canada
• Mexico

Market Segment by Type, covers

• Enzyme replacement therapy
• Substrate reduction therapy

Market Segment by Applications, can be divided into

• Non-neuronopathic Gaucher disease
• Neuronopathic Gaucher disease

There are 15 Chapters to deeply display the North America Gaucher Disease market.

Chapter 1, to describe Gaucher Disease Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Gaucher Disease, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Gaucher Disease, for each country, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications;

Chapter 10, Gaucher Disease market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022;

Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 13, to describe sales channel, distributors, traders, dealers etc.

Chapter 14 and 15, to describe Gaucher Disease Research Findings and Conclusion, Appendix, methodology and data source

Contents

1 MARKET OVERVIEW

1.1 Gaucher Disease Introduction
1.2 Market Analysis by Type
  1.2.1 Enzyme replacement therapy
  1.2.2 Substrate reduction therapy
1.3 Market Analysis by Applications
  1.3.1 Non-neuronopathic Gaucher disease
  1.3.2 Neuronopathic Gaucher disease
1.4 Market Analysis by Countries
  1.4.1 United States Status and Prospect (2012-2022)
  1.4.2 Mexico Status and Prospect (2012-2022)
  1.4.3 Canada Status and Prospect (2012-2022)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 Sanofi
  2.1.1 Profile
  2.1.2 Gaucher Disease Type and Applications
    2.1.2.1 Type
    2.1.2.2 Type
  2.1.3 Sanofi Gaucher Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.1.4 Business Overview
  2.1.5 Sanofi News
2.2 Shire
  2.2.1 Profile
  2.2.2 Gaucher Disease Type and Applications
    2.2.2.1 Type
    2.2.2.2 Type
  2.2.3 Shire Gaucher Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.2.4 Business Overview
  2.2.5 Shire News
2.3 Actelion Pharma
  2.3.1 Profile
  2.3.2 Gaucher Disease Type and Applications
    2.3.2.1 Type
    2.3.2.2 Type
  2.3.3 Actelion Pharma Gaucher Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.3.4 Business Overview
  2.3.5 Actelion Pharma News
2.4 Pfizer
  2.4.1 Profile
  2.4.2 Gaucher Disease Type and Applications
    2.4.2.1 Type
    2.4.2.2 Type
  2.4.3 Pfizer Gaucher Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.4.4 Business Overview
  2.4.5 Pfizer News
2.5 ISU Pharm
  2.5.1 Profile
  2.5.2 Gaucher Disease Type and Applications
    2.5.2.1 Type
    2.5.2.2 Type
  2.5.3 ISU Pharm Gaucher Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.5.4 Business Overview
  2.5.5 ISU Pharm News

3 NORTH AMERICA GAUCHER DISEASE MARKET COMPETITION, BY MANUFACTURER

3.1 North America Gaucher Disease Sales and Market Share by Manufacturer (2016-2017)
3.2 North America Gaucher Disease Revenue and Market Share by Manufacturer (2016-2017)
3.3 North America Gaucher Disease Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Gaucher Disease Manufacturer Market Share
  3.4.2 Top 5 Gaucher Disease Manufacturer Market Share
3.5 Market Competition Trend

4 NORTH AMERICA GAUCHER DISEASE MARKET ANALYSIS BY COUNTRIES

4.1 North America Gaucher Disease Sales Market Share by Countries
4.2 North America Gaucher Disease Sales by Countries (2012-2017)
4.3 North America Gaucher Disease Revenue (Value) by Countries (2012-2017)

5 NORTH AMERICA MARKET SEGMENTATION GAUCHER DISEASE BY TYPE

5.1 North America Gaucher Disease Sales, Revenue and Market Share by Type (2012-2017)
  5.1.1 North America Gaucher Disease Sales and Market Share by Type (2012-2017)
  5.1.2 North America Gaucher Disease Revenue and Market Share by Type (2012-2017)
5.2 Enzyme replacement therapy Sales Growth and Price
  5.2.1 North America Enzyme replacement therapy Sales Growth (2012-2017)
  5.2.2 North America Enzyme replacement therapy Price (2012-2017)
5.3 Substrate reduction therapy Sales Growth and Price
  5.3.1 North America Substrate reduction therapy Sales Growth (2012-2017)
  5.3.2 North America Substrate reduction therapy Price (2012-2017)

6 NORTH AMERICA MARKET SEGMENTATION GAUCHER DISEASE BY APPLICATION

6.1 North America Gaucher Disease Sales Market Share by Application (2012-2017)
6.2 Non-neuronopathic Gaucher disease Sales Growth (2012-2017)
6.3 Neuronopathic Gaucher disease Sales Growth (2012-2017)

7 UNITED STATES GAUCHER DISEASE SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

7.1 United States Gaucher Disease Revenue, Sales and Growth Rate (2012-2017)
7.2 United States Gaucher Disease Sales and Market Share by Type
7.3 United States Gaucher Disease Sales by Application (2012-2017)
7.4 United States Gaucher Disease Sales, Revenue and Market Share by Manufacturer
  7.4.1 United States Gaucher Disease Sales and Market Share by Manufacturer
  7.4.2 United States Gaucher Disease Revenue and Market Share by Manufacturer
7.5 United States Gaucher Disease Export and Import (2012-2017)

8 CANADA GAUCHER DISEASE SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

8.1 Canada Gaucher Disease Revenue, Sales and Growth Rate (2012-2017)
8.2 Canada Gaucher Disease Sales and Market Share by Type
8.3 Canada Gaucher Disease Sales by Application (2012-2017)
8.4 Canada Gaucher Disease Sales, Revenue and Market Share by Manufacturer
  8.4.1 Canada Gaucher Disease Sales and Market Share by Manufacturer
  8.4.2 Canada Gaucher Disease Revenue and Market Share by Manufacturer
8.5 Canada Gaucher Disease Export and Import (2012-2017)

9 MEXICO GAUCHER DISEASE SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

9.1 Mexico Gaucher Disease Revenue, Sales and Growth Rate (2012-2017)
9.2 Mexico Gaucher Disease Sales and Market Share by Type
9.3 Mexico Gaucher Disease Sales by Application (2012-2017)
9.4 Mexico Gaucher Disease Sales, Revenue and Market Share by Manufacturer
  9.4.1 Mexico Gaucher Disease Sales and Market Share by Manufacturer
  9.4.2 Mexico Gaucher Disease Revenue and Market Share by Manufacturer
9.5 Mexico Gaucher Disease Export and Import (2012-2017)

10 GAUCHER DISEASE MARKET FORECAST (2017-2022)

10.1 North America Gaucher Disease Sales, Revenue and Growth Rate (2017-2022)
10.2 Gaucher Disease Market Forecast by Countries (2017-2022)
  10.2.1 United States Gaucher Disease Forecast (2017-2022)
  10.2.2 Canada Gaucher Disease Forecast (2017-2022)
  10.2.3 Mexico Gaucher Disease Forecast (2017-2022)
10.3 Gaucher Disease Market Forecast by Type (2017-2022)
10.4 Gaucher Disease Market Forecast by Application (2017-2022)

11 GAUCHER DISEASE MANUFACTURING COST ANALYSIS

11.1 Gaucher Disease Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Gaucher Disease

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Gaucher Disease Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Gaucher Disease Major Manufacturers in 2016
12.4 Downstream Buyers

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Gaucher Disease Picture
Table Product Specifications of Gaucher Disease
Figure North America Sales Market Share of Gaucher Disease by Types in 2016
Table Types of Gaucher Disease
Figure Enzyme replacement therapy Picture
Table Major Manufacturers of Enzyme replacement therapy
Figure Substrate reduction therapy Picture
Table Major Manufacturers of Substrate reduction therapy
Table North America Gaucher Disease Sales Market Share by Applications in 2016
Table Applications of Gaucher Disease
Figure Non-neuronopathic Gaucher disease Picture
Figure Neuronopathic Gaucher disease Picture
Figure United States Gaucher Disease Revenue (Million USD) and Growth Rate (2012-2022)
Figure Mexico Gaucher Disease Revenue (Million USD) and Growth Rate (2012-2022)
Figure Canada Gaucher Disease Revenue (Million USD) and Growth Rate (2012-2022)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Gaucher Disease Type and Applications
Table Sanofi Gaucher Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Shire Basic Information, Manufacturing Base and Competitors
Table Shire Gaucher Disease Type and Applications
Table Shire Gaucher Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Actelion Pharma Basic Information, Manufacturing Base and Competitors
Table Actelion Pharma Gaucher Disease Type and Applications
Table Actelion Pharma Gaucher Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Gaucher Disease Type and Applications
Table Pfizer Gaucher Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table ISU Pharm Basic Information, Manufacturing Base and Competitors
Table ISU Pharm Gaucher Disease Type and Applications
Table ISU Pharm Gaucher Disease Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table North America Gaucher Disease Sales by Manufacturer (2016-2017)
Figure North America Gaucher Disease Sales Market Share by Manufacturer in 2016
Figure North America Gaucher Disease Sales Market Share by Manufacturer in 2017
Table North America Gaucher Disease Revenue by Manufacturer (2016-2017)
Figure North America Gaucher Disease Revenue Market Share by Manufacturer in 2016
Figure North America Gaucher Disease Revenue Market Share by Manufacturer in 2017
Table North America Gaucher Disease Price by Manufacturers (2016-2017)
Figure Top 3 Gaucher Disease Manufacturer Market Share in 2016
Figure Top 3 Gaucher Disease Manufacturer Market Share in 2017
Figure Top 5 Gaucher Disease Manufacturer Market Share in 2016
Figure Top 5 Gaucher Disease Manufacturer Market Share in 2017
Figure North America Gaucher Disease Sales and Growth (2012-2017)
Table North America Gaucher Disease Sales by Countries (2012-2017)
Table North America Gaucher Disease Sales Market Share by Countries (2012-2017)
Figure North America 2012 Gaucher Disease Sales Market Share by Countries
Figure North America 2016 Gaucher Disease Sales Market Share by Countries
Figure North America Gaucher Disease Revenue and Growth (2012-2017)
Table North America Gaucher Disease Revenue by Countries (2012-2017)
Table North America Gaucher Disease Revenue Market Share by Countries (2012-2017)
Table North America 2012 Gaucher Disease Revenue Market Share by Countries
Table North America 2016 Gaucher Disease Revenue Market Share by Countries
Table North America Gaucher Disease Sales by Type (2012-2017)
Table North America Gaucher Disease Sales Share by Type (2012-2017)
Table North America Gaucher Disease Revenue by Type (2012-2017)
Table North America Gaucher Disease Revenue Share by Type (2012-2017)
Figure North America Enzyme replacement therapy Sales Growth (2012-2017)
Figure North America Enzyme replacement therapy Price (2012-2017)
Figure North America Substrate reduction therapy Sales Growth (2012-2017)
Figure North America Substrate reduction therapy Price (2012-2017)
Table North America Gaucher Disease Sales by Application (2012-2017)
Table North America Gaucher Disease Sales Share by Application (2012-2017)
Figure North America Non-neuronopathic Gaucher disease Sales Growth (2012-2017)
Figure North America Neuronopathic Gaucher disease Sales Growth (2012-2017)
Figure United States Gaucher Disease Revenue and Growth (2012-2017)
Figure United States Gaucher Disease Sales and Growth (2012-2017)
Table United States Gaucher Disease Sales by Type (2012-2017)
Table United States Gaucher Disease Sales Market Share by Type (2012-2017)
Table United States Gaucher Disease Sales by Application (2012-2017)
Table United States Gaucher Disease Sales Market Share by Application (2012-2017)
Table United States Gaucher Disease Sales by Manufacturer (2016-2017)
Figure United States Gaucher Disease Sales Market Share by Manufacturer in 2016
Figure United States Gaucher Disease Sales Market Share by Manufacturer in 2017
Table United States Gaucher Disease Revenue by Manufacturer (2016-2017)
Figure United States Gaucher Disease Revenue Market Share by Manufacturer in 2016
Figure United States Gaucher Disease Revenue Market Share by Manufacturer in 2017
Table United States Gaucher Disease Export and Import (2012-2017)
Figure Canada Gaucher Disease Revenue and Growth (2012-2017)
Figure Canada Gaucher Disease Sales and Growth (2012-2017)
Table Canada Gaucher Disease Sales by Type (2012-2017)
Table Canada Gaucher Disease Sales Market Share by Type (2012-2017)
Table Canada Gaucher Disease Sales by Application (2012-2017)
Table Canada Gaucher Disease Sales Market Share by Application (2012-2017)
Table Canada Gaucher Disease Sales by Manufacturer (2016-2017)
Figure Canada Gaucher Disease Sales Market Share by Manufacturer in 2016
Figure Canada Gaucher Disease Sales Market Share by Manufacturer in 2017
Table Canada Gaucher Disease Revenue by Manufacturer (2016-2017)
Figure Canada Gaucher Disease Revenue Market Share by Manufacturer in 2016
Figure Canada Gaucher Disease Revenue Market Share by Manufacturer in 2017
Table Canada Gaucher Disease Export and Import (2012-2017)
Figure Mexico Gaucher Disease Revenue and Growth (2012-2017)
Figure Mexico Gaucher Disease Sales and Growth (2012-2017)
Table Mexico Gaucher Disease Sales by Type (2012-2017)
Table Mexico Gaucher Disease Sales Market Share by Type (2012-2017)
Table Mexico Gaucher Disease Sales by Application (2012-2017)
Table Mexico Gaucher Disease Sales Market Share by Application (2012-2017)
Table Mexico Gaucher Disease Sales by Manufacturer (2016-2017)
Figure Mexico Gaucher Disease Sales Market Share by Manufacturer in 2016
Figure Mexico Gaucher Disease Sales Market Share by Manufacturer in 2017
Table Mexico Gaucher Disease Revenue by Manufacturer (2016-2017)
Figure Mexico Gaucher Disease Revenue Market Share by Manufacturer in 2016
Figure Mexico Gaucher Disease Revenue Market Share by Manufacturer in 2017
Table Mexico Gaucher Disease Export and Import (2012-2017)
Figure North America Gaucher Disease Sales, Revenue and Growth Rate (2017-2022)
Table North America Gaucher Disease Sales Forecast by Countries (2017-2022)
Table North America Gaucher Disease Market Share Forecast by Countries (2017-2022)
Figure United States Gaucher Disease Sales Forecast (2017-2022)
Figure Canada Gaucher Disease Sales Forecast (2017-2022)
Figure Mexico Gaucher Disease Sales Forecast (2017-2022)
Table North America Gaucher Disease Sales Forecast by Type (2017-2022)
Table North America Gaucher Disease Market Share Forecast by Type (2017-2022)
Table North America Gaucher Disease Sales Forecast by Application (2017-2022)
Table North America Gaucher Disease Market Share Forecast by Application (2017-2022)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Gaucher Disease
Figure Manufacturing Process Analysis of Gaucher Disease
Figure Gaucher Disease Industrial Chain Analysis
Table Raw Materials Sources of Gaucher Disease Major Manufacturers in 2016
Table Major Buyers of Gaucher Disease
Table Distributors/Traders/ Dealers List